OR, good question.
I'm not an investor in that other RAS device company, but based on my observations from watching it, and many other stocks, I'd conclude that it will continue on it's present trajectory unless there is a change in perception or material conditions from which the company currently operates.
Before the merger with the SPAC, it was a high-profile development company with a few deep-pocket investors. And I'd also conclude that most of the attraction was due to the fact that the SPAC was already listed on the NYSE. Not necessarily a solid justification for my money, b/c I felt it fell into the category of a momentum investment. The small amount of awarded IP was/is the deciding factor in my mind.
It would be interesting to know how long ago any additional patent applications were filed, to see the length of time. I'd have to know that to reach any conclusion(s) if there are questions regarding the design that may be causing any delays for an award.
Clearly, my previous speculation has been confirmed by the decline in sp since the IPO. My guess was some of the venture capital was involved for quick profit pre IPO, with the plan to sell after the sp jumped soon there after. Someone's selling. I haven't been tracking the volume on the sell side, but for every sell there's been a buy. But at a lower sp. You could argue, if nothing has changed then the lower sp is a bargain. Unless it keeps going down.
The company isn't far enough along for me to consider it at this time, and the sp has too much room below where it presently sits for my liking. JMO.
This is a terrible example of how a few on this board represent themselves, or misrepresent themselves. I'd give them the benefit of the doubt, if their message(s) were few and brief. But the level of repetitive insistence of the device superiority, and specific investor participation created many doubts IMO. Again JMO.
I don't wish anyone ill will. Thankfully there's a specific board for that other company and it would appear it's fading from here.
Back to why we're here... IMO, the next 8-10 weeks may be very choppy, and how it may effect our sp. All b/c of trading volume, and those that would posture for shorting this company. Not a surprise to me.
But there is good news if you look for it. We're closer to the desired outcome than we were 1 year ago. With undisputed professional confirmation that ENOS performs as expected, from arguably THE KOL in RAS - Dr. Ricardo Esptape.
Further in support of our continued success, a few specific members speculated that we wouldn't get here, or it would be a delayed series of self-inflicted mistakes/disasters. Happy to see those predictions were pure BS. And we've established Titan Living Labs along the way.
Pretty impressive.
Good luck to all. Regards,BK.
